title: Reversible increase in FGF23 in a hypophosphatemic renal and bone disease linked to antiviral therapy by adefovir.
authors.affiliation: Faculté de médecine et de pharmacie, université Mohamed I, Oujda, Morocco. Electronic address: ilinda19@yahoo.fr.
authors.forename: Linda
authors.initials: L
authors.lastname: Ichchou
authors.forename: Stéphanie
authors.initials: S
authors.lastname: Rist
authors.forename: Eric
authors.initials: E
authors.lastname: Lespessailles
authors.forename: Dominique
authors.initials: D
authors.lastname: Prié
authors.forename: Claude-Laurent
authors.initials: CL
authors.lastname: Benhamou
mesh_terms: D000225:Adenine / Q000009:adverse effects / Q000031:analogs & derivatives*; D000368:Aged; D000998:Antiviral Agents / Q000009:adverse effects*; D001847:Bone Diseases / Q000139:chemically induced* / Q000378:metabolism; D005260:Female; D000089703:Fibroblast Growth Factor-23; D005346:Fibroblast Growth Factors / Q000096:biosynthesis*; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D006801:Humans; D017674:Hypophosphatemia / Q000139:chemically induced / Q000378:metabolism; D007674:Kidney Diseases / Q000139:chemically induced* / Q000378:metabolism; D063065:Organophosphonates / Q000009:adverse effects*
chemical_list: D000998:Antiviral Agents; C000717427:FGF23 protein, human; D063065:Organophosphonates; D005346:Fibroblast Growth Factors; C053001:adefovir; D000089703:Fibroblast Growth Factor-23; D000225:Adenine
keywords: Antiviral therapy; FGF23; Hepatitis B; Hypophosphatemia